Yeast vaccine: trials of a drug against several types of cancer are being completed in Russia

“Cheaper than foreign” In 2020, the research and production company “Combiotech” and the Kirov manufacturer of vaccines “Nanolek” announced on a joint project to develop and market the first domestic quadrivalent human papillomavirus (HPV) vaccine. It is called quadrivalent because it protects against the four most common dangerous strains of the virus. HPV causes cancer … Read more

The Outlast Trials Rilis Early Access di Mei 2023 • Jagat Play

How many of you have heard of the developer Red Barrels before? For those who love the horror genre, this name will certainly be familiar. That’s right, they are the brains of the Outlast series, which managed to frighten many gamers through two phenomenal series. With a lore that is related to one another, there … Read more

The final stage of the clinical trials of the ARVAC Cecilia Grierson vaccine against Covid -19 and its variants begins

With the economic support of $1,100 million from the I+D+i Agency, through the Argentine Sectorial Fund (FONARSEC), the ARVAC Cecilia Grierson national vaccine against the variants of SARS-CoV-2 circulating in the region, entered the last stretch of clinical trials (stage 2 of phase 2/3). The announcement was made in an institutional act in the Tank … Read more

The Argentine vaccine against the coronavirus has entered the last stage of development and they are looking for volunteers to test it | Phase II and III trials

With the expectation of commercializing the Argentine anticovid vaccine “Arvac Cecilia Grierson” After half of the year, next Monday the search for 2,200 volunteers over the age of 18, that have a complete vaccination scheme, to test it. Phase II and III tests of the Argentine vaccine will be carried out at the Cemic University … Read more

Phase 2/3 clinical trials of the Argentine vaccine against COVID-19 began

The Minister of Science, Technology and Innovation, Daniel Filmus, held a meeting today at the National University of San Martín with the team that develops the ARVAC Cecilia Grierson vaccine against COVID-19, led by Dr. Juliana Cassataro, to know the progress of phase 2/3 trials. The President of the R+D+i Agency, Fernando Peirano, also participated … Read more

The breast cancer vaccine has passed the first phase of human trials

Dr. Nora Disis in breast cancer research recently said, “I was the only woman in my oncology class with a scholarship, so they made me go to the breast cancer clinic.” Disis, director of the Cancer Vaccine Institute at UW Medicine and a faculty member at the University of Washington and Fred Hutch Cancer Center, … Read more

Chinese company Sinopharm’s mRNA vaccine gets approval for clinical trials

In a statement made by the company, it was reported that the National Administration of Medical Products of China has approved clinical trials of the vaccine candidate. In the statement, it was stated that the vaccine candidate, modeled after the Omicron variant, contains a genetically designed antigen that targets the spike protein that allows the … Read more

This Startup Trials the Dangerous Practice of ‘Blowing Out’ the Sun

Jakarta – The idea of ​​’solar geoengineering’ or shooting stratospheric particles to reduce heat Sunsometimes nicknamed dimmed the Sun, is considered to help reduce global warming and climate change. Even a startup called Make Sunsets claims to have tried it. The Washington Post reported that the company’s CEO and founder, Luke Iseman, had flown a … Read more

The ANMAT authorized the trials for Phase II and III of the Argentine vaccine against Covid-19

The tests will be carried out on adult volunteers previously vaccinated against the SARS-CoV-2 virus. The National Administration of Medicines, Food and Medical Technology (ANMAT) reported this Monday that it authorized the start of the Phase II and III studies to assess the safety, tolerability and immunogenicity of the national vaccine “ARVAC Cecilia Grierson” against … Read more

German pharmaceutical company BioNTech begins clinical trials of a malaria vaccine

ANKARA AA – Sun German pharmaceutical BioNTech announced this Friday that it began clinical trials of a malaria vaccine. In a statement, the pharmaceutical company reported that phase 1 trials of the BNT165b1 vaccine will be done with about 60 healthy participants without previous or current malaria infection from various locations in the US and … Read more